Reporting for the family-office world.

An Exclusive Behind-The-Scenes Look at Avisa Diagnostics Inc.’s Innovation We invite you to join us for an exclusive look at Avisa Diagnostics’ innovative platform and how it is transforming healthcare. Avisa is a clinical-stage medical device company developing the Avisa BreathTest™, (ABT), a novel drug/device combination biomarker technology platform. The Company has established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis and community-acquired pneumonia, which demonstrated positive safety and clinical efficacy results. There are 1.7 million patients on ventilators annually in the U.S, with 400,000 of these patients diagnosed with ventilator-associated pneumonia, resulting in a mortality rate of 30% to 50%.

Join Our Exclusive Family Office Investor Event to learn more about Arterez. Cardiovascular Disease (CVD) is the world’s leading chronic killer impacting more than one-third of the world’s population. US direct and indirect healthcare costs due to CVD is expected to grow to an estimated $1.5 trillion by 2030. Among the top 150 developing nations worldwide, CVD is the largest health risk and cost. Dr. J.B. Tunac and Arterez believe they have discovered the multi-factorial root causes of chronic vascular disease and that those can be identified, characterized, cured and ultimately prevented. The company’s first drug, Embotricin™, targets healing at the cellular level rather than targeting symptoms. The company has also developed a biomarker panel for treatment monitoring, known as GlycoCardia™ that can also be used for disease identification, staging and classification. Embotricin™ proved to prevent and reverse arterial plaques in models and proved non-toxic up to 300x the effective dose. First in-human studies are expected to begin Q1 2023.

Join Leading Family Offices for a Deep Dive into Corporate Security Solutions, Inc. The Corporate Security Solutions team is led by licensed private investigator John Glavin who has 30+ years of experience helping family offices and leading corporations handle complex security requirements. Services include corporate investigations, litigation and legal disputes, due diligence, risk analysis and threat, family issues related to divorce and other domestic issues, background checks, business investigation, cybersecurity, insurance, EEOC, sexual harassment claims, and related matters

Join Our Exclusive Family Office Networks Investor Event to learn more about Estonia. Estonia is the #1 country in billion-dollar companies (“unicorns”) founded per capita in Europe and #2 globally and leads Europe in the founding of new tech startups. For the last 5 years, its startup sector has grown 30% YoY, whether measured by revenues, jobs created, or fundraising. This trajectory will result in 30% of Estonia’s GDP coming from the tech sector by 2030. During the webinar, you will learn how family offices can participate in Estonia’s exciting and vibrant startup sector.

Join us for an exclusive behind-the-scenes look at Cerebri AI, a cutting-edge software company. The Cerebri AI CVX platform is an end-to-end AI & data science platform that automates AI processes from data engineering to actions & offers. Cerebri AI combines the power of machine learning and cloud computing to score new customer events in real-time and drive revenue through better engagement, more sales, and lower churn. It represents the fastest way to get to market with production-ready AI insights while not forgoing quality.

Join our exclusive Family Office Event to learn more about global trends and The Democracy International Fund ETF (ticker DMCY). DMCY provides an international equity portfolio re-weighted toward democracies and away from authoritarianism leveraging The Economist’s Democracy Index. Why attend this webinar? Learn more about DMCY and global trends in the decline of democracies that embrace ideals such as freedom of speech, fair elections, and civil liberties, and the rise of authoritarian states with links to human rights abuses, media censorship, judicial corruption, and a lack of free and fair elections.

Join the Family Office Networks’ Webinar Series to learn more about tZERO, a leader in financial innovation and liquidity for private companies. tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) provide an innovative liquidity platform for private companies, real estate assets, and funds with diverse strategies across a variety of industries and geographies. The company offers institutional-grade solutions for issuers looking to digitize their existing capital table or future capital raises and trade on a regulated alternative trading system, providing a pathway to secondary market liquidity. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. For more information on tZERO, please visit https://www.tzero.com/.

Join Leading Family Offices for a Deep Dive into Multifamily Acquisitions Outsourcing. Offerd is revolutionizing the Commercial Real Estate (CRE) investment market with a unique Third Party Acquisitions model. The company leverages an innovative technology platform, sophisticated data analysis and integrated deal-making services to execute targeted sourcing and drive direct acquisitions. Starting with the multifamily segment, Offerd is committed to powering the buyside of CRE. Building on significant growth in the past six months, Offerd is now undergoing its first institutional capital raise and is seeking accredited investors to help fuel further expansion. Who should join: Investors open to considering a direct investment in Offerd; LPs seeking passive investments in multifamily assets; and Family Offices seeking an effective platform to source deals directly.

Wakefield’s experienced founding team has developed a trade-secret process to produce a sustainable, clean carbon from organic waste. Wakefield BioChar’s products and services: -Enhance soil health for agricultural and landscaping industries through multiple distribution channels -Replace carbon black, a common petroleum-based feedstock for plastics and rubber -Facilitate post-industrial processing measures that create carbon credit trading opportunities -Contribute meaningfully to reversing climate change Wakefield is rapidly moving from commercialization to sustainable operating levels across multiple product and service lines, and is on track to surpass full-year 2020 revenue by mid-April, 2021.

This exclusive webinar will inform and inspire leading Family Offices to be a part of the Art Revolution. The LATAM Art Fund founder, Paul Hollingworth will be presenting on the Latin American Art Opportunities. The fund focus is mainly on established “liquid” artists with a proven auction history and a low coefficient of variation, as well as “active” emerging painters with a more limited but tangible auction history. ART offers investors a low volatility, low-correlated, high risk-adjusted return alternative asset with portfolio diversifier characteristics. The art market is valued in the US to be $1.7 trillion dollars.